NDAINJECTIONINJECTABLE
Approved
Jun 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYDROCORTONE (hydrocortisone sodium phosphate) is a rapid-acting corticosteroid administered by injection for acute inflammatory and allergic conditions. It works by suppressing immune response and reducing inflammation across multiple organ systems. The product is a legacy injectable steroid with broad utility in emergency and hospital settings.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30%), brand teams are likely in consolidation or defensive mode with reduced headcount.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HYDROCORTONE offers limited career growth potential; the product is a mature, low-engagement asset with minimal linked job openings and declining commercial momentum. Career development on this brand centers on operational efficiency and defensive market tactics rather than growth strategy or innovation.
Brand ManagerField Sales Representative
Worked on HYDROCORTONE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.